These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1826015)

  • 21. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes.
    Conlon K; Osborne J; Morimoto C; Ortaldo JR; Young HA
    Eur J Immunol; 1995 Mar; 25(3):644-8. PubMed ID: 7705392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.
    Sugita K; Hirose T; Rothstein DM; Donahue C; Schlossman SF; Morimoto C
    J Immunol; 1992 Nov; 149(10):3208-16. PubMed ID: 1358967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2-R beta expression and function within resting CD8+ T cells preferentially segregate with the CD45R0+ subset.
    Moire N; Rouleau M; Metivier D; Charpentier B; Senik A
    Eur Cytokine Netw; 1991; 2(5):319-27. PubMed ID: 1839506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD; Schreiber H; Bluestone JA
    J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
    Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
    J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.
    Rothstein DM; Yamada A; Schlossman SF; Morimoto C
    J Immunol; 1991 Feb; 146(4):1175-83. PubMed ID: 1671403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
    Gangemi RM; Swack JA; Gaviria DM; Romain PL
    J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
    Yang SY; Rhee S; Welte K; Dupont B
    J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD28- T lymphocytes. Antigenic and functional properties.
    Azuma M; Phillips JH; Lanier LL
    J Immunol; 1993 Feb; 150(4):1147-59. PubMed ID: 8381831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
    Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
    J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development.
    Chang JF; Thomas CA; Kung JT
    J Immunol; 1991 Aug; 147(3):860-6. PubMed ID: 1830601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic properties and cytotoxic functions of human CD8+ cells expressing the CD57 antigen.
    Yamashita N; Nguyen L; Fahey JL; Clement LT
    Nat Immun; 1993; 12(2):79-91. PubMed ID: 7686417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
    Ioannides CG; Rashed S; Fisk B; Fan D; Itoh K; Freedman RS
    Lymphokine Cytokine Res; 1991 Aug; 10(4):307-15. PubMed ID: 1932375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.